NEU 2.99% $20.10 neuren pharmaceuticals limited

It is interesting because given the start of ACAD's share price...

  1. 1,633 Posts.
    lightbulb Created with Sketch. 149
    It is interesting because given the start of ACAD's share price recovery the gap between their market cap and NEU has grown. The FX affects has amplified this.

    If that trend continues (whilst NEU remains stubborn in this range) then a heavily scrip-based deal becomes more likely in my mind. I think it is probably unlikely but if Acadia recovered towards the 5B USD mark whilst we floundered around the 1.65-1.75B ~ USD market ACAD shareholders may not mind getting diluted oblivion on the back of 2 (maybe 3) positive phase 2 indications, and a replacement to Daybue when Trof is out of marketing exclusivity down the road.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.10
Change
-0.620(2.99%)
Mkt cap ! $2.569B
Open High Low Value Volume
$20.41 $20.45 $19.92 $5.947M 296.0K

Buyers (Bids)

No. Vol. Price($)
1 999 $20.10
 

Sellers (Offers)

Price($) Vol. No.
$20.19 10 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.